TY - JOUR
T1 - Invariant NKT cell development requires a full complement of functional CD3 ζ immunoreceptor tyrosine-based activation motifs
AU - Becker, Amy M.
AU - Blevins, Jon S.
AU - Tomson, Farol L.
AU - Eitson, Jennifer L.
AU - Medeiros, Jennifer J.
AU - Yarovinsky, Felix
AU - Norgard, Michael V.
AU - Van Oers, Nicolai S C
PY - 2010/6/15
Y1 - 2010/6/15
N2 - Invariant NKT (iNKT) cells regulate early immune responses to infections, in part because of their rapid release of IFN-γ and IL-4. iNKT cells are proposed to reduce the severity of Lyme disease following Borrelia burgdorferi infection. Unlike conventional T cells, iNKT cells express an invariant αβ TCR that recognizes lipids bound to the MHC class I-like molecule, CD1d. Furthermore, these cells are positively selected following TCR interactions with glycolipid/CD1d complexes expressed on CD4+CD8 + thymocytes. Whereas conventional T cell development can proceed with as few as 4/10 CD3 immunoreceptor tyrosine-based activation motifs (ITAMs), little is known about the ITAM requirements for iNKT cell selection and expansion.We analyzed iNKT cell development in CD3 ζ transgenic lines with various tyrosine-to-phenylalanine substitutions (YF) that eliminated the functions of the first (YF1,2), third (YF5,6), or all three (YF1-6) CD3 ζ ITAMs. iNKT cell numbers were significantly reduced in the thymus, spleen, and liver of all YF mice compared with wild type mice. The reduced numbers of iNKT cells resulted from significant reductions in the expression of the early growth response 2 and promyelocytic leukemia zinc finger transcription factors. In the mice with few to no iNKT cells, there was no difference in the severity of Lyme arthritis compared with wild type controls, following infections with the spirochete B. burgdorferi. These findings indicate that a full complement of functional CD3 ζ ITAMs is required for effective iNKT cell development.
AB - Invariant NKT (iNKT) cells regulate early immune responses to infections, in part because of their rapid release of IFN-γ and IL-4. iNKT cells are proposed to reduce the severity of Lyme disease following Borrelia burgdorferi infection. Unlike conventional T cells, iNKT cells express an invariant αβ TCR that recognizes lipids bound to the MHC class I-like molecule, CD1d. Furthermore, these cells are positively selected following TCR interactions with glycolipid/CD1d complexes expressed on CD4+CD8 + thymocytes. Whereas conventional T cell development can proceed with as few as 4/10 CD3 immunoreceptor tyrosine-based activation motifs (ITAMs), little is known about the ITAM requirements for iNKT cell selection and expansion.We analyzed iNKT cell development in CD3 ζ transgenic lines with various tyrosine-to-phenylalanine substitutions (YF) that eliminated the functions of the first (YF1,2), third (YF5,6), or all three (YF1-6) CD3 ζ ITAMs. iNKT cell numbers were significantly reduced in the thymus, spleen, and liver of all YF mice compared with wild type mice. The reduced numbers of iNKT cells resulted from significant reductions in the expression of the early growth response 2 and promyelocytic leukemia zinc finger transcription factors. In the mice with few to no iNKT cells, there was no difference in the severity of Lyme arthritis compared with wild type controls, following infections with the spirochete B. burgdorferi. These findings indicate that a full complement of functional CD3 ζ ITAMs is required for effective iNKT cell development.
UR - http://www.scopus.com/inward/record.url?scp=77953628836&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953628836&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.0902058
DO - 10.4049/jimmunol.0902058
M3 - Article
C2 - 20483726
AN - SCOPUS:77953628836
SN - 0022-1767
VL - 184
SP - 6822
EP - 6832
JO - Journal of Immunology
JF - Journal of Immunology
IS - 12
ER -